RELMADA THERAPEUTICS, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Relmada Therapeutics, Inc. on September 23, 2015. The filing serves as a Regulation FD disclosure regarding an upcoming corporate presentation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report announcing a conference presentation and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces the Company's scheduled appearance at the Ladenburg Thalmann 2015 Healthcare Conference on September 29, 2015.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the conference presentation. The filing explicitly states that the information is "furnished" and not "filed" for purposes of the Securities Exchange Act of 1934. No specific guidance, risks, contingencies, or unusual items are detailed within the text of this 8-K.
Key Facts for Investor Verification
- The Company is scheduled to present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29, 2015, at 3 PM.
- A press release (Exhibit 99.1) and corporate presentation (Exhibit 99.2) are attached to this filing and should be reviewed for detailed company updates.
- This 8-K does not contain audited financial data or specific operational metrics.